Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations.
暂无分享,去创建一个
[1] I. Goldberg,et al. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. , 1993, The Journal of clinical investigation.
[2] S. Grundy,et al. Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. , 1992, Journal of lipid research.
[3] C. Mann,et al. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. , 1991, The Journal of clinical investigation.
[4] P. Barter,et al. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[5] S. Eisenberg,et al. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. , 1991, The Journal of clinical investigation.
[6] M. Eriksson,et al. Influence of age on the metabolism of plasma low density lipoproteins in healthy males. , 1991, The Journal of clinical investigation.
[7] W. Blaner,et al. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. , 1990, The Journal of clinical investigation.
[8] M. King,et al. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.
[9] R. Krauss,et al. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. , 1990, Arteriosclerosis.
[10] L. Fong,et al. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. , 1990, Biochimica et biophysica acta.
[11] Y. Arad,et al. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. , 1990, Journal of lipid research.
[12] N. Miller,et al. Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. , 1989, Arteriosclerosis.
[13] F. Rinninger,et al. Regulation of the selective uptake of high density lipoprotein-associated cholesteryl esters by human fibroblasts and Hep G2 hepatoma cells. , 1988, Journal of lipid research.
[14] N. Le,et al. Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol. , 1988, Metabolism: clinical and experimental.
[15] N. Le,et al. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins. , 1988, Journal of lipid research.
[16] S. Grundy,et al. Hypertriglyceridemia: Causes and Relation to Coronary Heart Disease , 1988, Seminars in thrombosis and hemostasis.
[17] S. J. Smith,et al. An international collaborative study on standardization of apolipoproteins A-I and B. Part I. Evaluation of a lyophilized candidate reference and calibration material. , 1987, Clinical chemistry.
[18] G. Franceschini,et al. Reduced HDL2 levels in myocardial infarction patients without risk factors for atherosclerosis. , 1987, Atherosclerosis.
[19] A. Tall,et al. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. , 1987, The Journal of clinical investigation.
[20] A. Sniderman,et al. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. , 1986, The Journal of clinical investigation.
[21] L. Wallentin,et al. HDL2 and HDL3 lipid levels in coronary artery disease. , 1986, Atherosclerosis.
[22] A. Tall,et al. Enrichment of endothelial cell arachidonate by lipid transfer from high density lipoproteins: relationship to prostaglandin I2 synthesis. , 1985, Journal of lipid research.
[23] S. Grundy,et al. Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. , 1985, The Journal of clinical investigation.
[24] N. Le,et al. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss. , 1985, The Journal of clinical investigation.
[25] D. Steinberg,et al. Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. , 1985, The Journal of biological chemistry.
[26] A. Kissebah,et al. Low Density Lipoprotein Metabolism in Familial Combined Hyperlipidemia: Mechanism of the Multiple Lipoprotein Phenotypic Expression , 1984, Arteriosclerosis.
[27] S. Eisenberg,et al. High density lipoprotein metabolism. , 1984, Journal of lipid research.
[28] A. Sniderman,et al. Apoproteins B and A-I and coronary artery disease in humans. , 1984, Arteriosclerosis.
[29] W. Brown,et al. Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects. , 1983, Journal of lipid research.
[30] I. Goldberg,et al. Increased Catabolism of Native and Cyclohexanedione‐Modified Low Density Lipoprotein in Subjects with Myeloproliferative Diseases , 1983, Arteriosclerosis.
[31] S. Grundy,et al. Overproduction of Low Density Lipoproteins Associated with Coronary Heart Disease , 1983, Arteriosclerosis.
[32] A. Sniderman,et al. Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. , 1982, Annals of internal medicine.
[33] L. Wallentin,et al. High density lipoprotein and other lipoproteins in normolipidaemic and hypertriglyceridaemic (type IV) men with coronary artery disease , 1981, European journal of clinical investigation.
[34] Norman R. Draper,et al. Applied regression analysis (2. ed.) , 1981, Wiley series in probability and mathematical statistics.
[35] A. Kissebah,et al. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. , 1981, Metabolism: clinical and experimental.
[36] M Halperin,et al. Correlations of Plasma High‐density Lipoprotein Cholesterol Levels with Other Plasma Lipid and Lipoprotein Concentrations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.
[37] P. Nestel,et al. Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals. , 1980, Metabolism: clinical and experimental.
[38] R. Bawol,et al. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. , 1980, The New England journal of medicine.
[39] A. Chait,et al. Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia , 1980, European journal of clinical investigation.
[40] L. Wilkins. Plasma Lipid Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study THE LIPID RESEARCH CLINICS PROGRAM EPIDEMIOLOGY COMMITTEE , 1979, Circulation.
[41] M C Hjortland,et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.
[42] A Kagan,et al. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. , 1976, The New England journal of medicine.
[43] G. Miller,et al. PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.
[44] A. Motulsky,et al. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. , 1973, The Journal of clinical investigation.
[45] D. Bilheimer,et al. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.
[46] J. Glomset,et al. The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.
[47] A. Mcfarlane,et al. Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.
[48] R. Havel,et al. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.
[49] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[50] A. Tall. Plasma lipid transfer proteins. , 1995, Annual review of biochemistry.
[51] M. Austin. Plasma triglyceride and coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[52] G. Rothblat,et al. Influence of high density lipoprotein on esterified cholesterol stores in macrophages and hepatoma cells. , 1990, Arteriosclerosis.
[53] S. Grundy,et al. Familial combined hyperlipidemia workshop , 1989 .
[54] J. Ordovás,et al. Genetics and abnormalities in metabolism of lipoproteins. , 1988, Clinical chemistry.
[55] S. Grundy,et al. Low density lipoprotein metabolism in hypertriglyceridemic and normolipidemic patients with coronary heart disease. , 1985, Journal of lipid research.
[56] P. Allhoff,et al. The Lipid Research Clinics Program Prevalence Study. , 1980, Circulation.